Spots Global Cancer Trial Database for haploidentical
Every month we try and update this database with for haploidentical cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Haploidentical NK-cell Infusion in Acute Myeloid Leukemia | NCT01947322 | Acute Myeloid L... | Allogenic NK ce... | 18 Years - 65 Years | Assistance Publique - Hôpitaux de Paris | |
Stem Cell Transplant Using Peripheral and Cord Blood Stem Cells to Treat Severe Aplastic Anemia and Myelodysplastic Syndrome | NCT00604201 | Myelodysplastic... Severe Aplastic... | Umbilical Cord ... | 4 Years - 75 Years | National Institutes of Health Clinical Center (CC) | |
GVHD Prophylaxis With Methotrexate in Haploidentical HCT Using Posttransplant Cyclophosphamide | NCT04622956 | Graft Vs Host D... Hematopoietic N... | Methotrexate In... | 18 Years - 70 Years | University of Sao Paulo General Hospital | |
ALT-801-activated Natural Killer Cells After FLAG Induction for Acute Myeloid Leukemia | NCT01478074 | Acute Myeloid L... | G-CSF Cytarabine Fludarabine Donor Natural K... ALT-801 | 2 Years - 59 Years | Altor BioScience | |
Haploidentical NK-cell Infusion in Acute Myeloid Leukemia | NCT01947322 | Acute Myeloid L... | Allogenic NK ce... | 18 Years - 65 Years | Assistance Publique - Hôpitaux de Paris | |
Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide | NCT03088709 | Acute Myeloid L... Acute Lymphocyt... Myelodysplastic... Non-hodgkin Lym... Chronic Lymphoc... | Cyclophosphamid... Tacrolimus Mycophenolate m... Haploidentical ... | 16 Years - 90 Years | Loyola University | |
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome | NCT03173937 | Severe Aplastic... Hypo-Plastic MD... Myelodysplastic... | Omidubicel (for... Miltenyi CliniM... | 4 Years - 75 Years | National Institutes of Health Clinical Center (CC) | |
Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic Cancers | NCT01135329 | Lymphoma Leukemia Myelodysplastic... | Fludarabine Busulfan Cyclophosphamid... Mycophenolate M... Tacrolimus | 6 Months - 75 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
Combined T Cell Depleted Haploidentical Peripheral Blood Stem Cell and Unrelated Umbilical Cord Blood Transplantation in Patients With Hematologic Malignancies Using a Total Lymphoid Irradiation Based Preparative Regimen | NCT02199041 | Hematological M... | Cyclophosphamid... Thiotepa Fludarabine Melphalan Mesna G-CSF Mycophenolate m... Tacrolimus Methylprednisol... Total lymphoid ... Lymphocyte infu... CliniMACS | - 21 Years | St. Jude Children's Research Hospital | |
Haploidentical Donor vs mMUD in Hematological Malignancies | NCT03275636 | AML ALL MDS | Peripheral bloo... | 18 Years - | DKMS gemeinnützige GmbH | |
Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression | NCT03480360 | Acute Myeloid L... Chronic Lymphoc... Chronic Myeloid... Myelodysplasia Myeloproliferat... Myelofibrosis Lymphoma Lymphoma, Non-H... Plasma Cell Dis... | Cyclophosphamid... Fludarabine Total Body Irra... Tacrolimus cellcept g-csf Peripheral Bloo... | 18 Years - 75 Years | Dartmouth-Hitchcock Medical Center | |
Stem Cell Transplant Using Peripheral and Cord Blood Stem Cells to Treat Severe Aplastic Anemia and Myelodysplastic Syndrome | NCT00604201 | Myelodysplastic... Severe Aplastic... | Umbilical Cord ... | 4 Years - 75 Years | National Institutes of Health Clinical Center (CC) | |
Evaluating the Use of RFT5-dgA to Deplete Alloreactive Cells Prior to Haploidentical Stem Cell Transplantation | NCT00586547 | Leukemia Cancer | T-Cell Infusion... T-Cell Infusion... T-Cell Infusion... T-Cell Infusion... T-Cell Infusion... | - | Baylor College of Medicine | |
Peripheral Blood Stem Cell Transplantation (PBSCT)From Haploidentical Related Donors | NCT00618969 | Hematologic Neo... Anemia, Aplasti... Hemoglobinuria,... Multiple Myelom... | haploidentical ... | 18 Years - 75 Years | University of Arizona | |
Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic Cancers | NCT01135329 | Lymphoma Leukemia Myelodysplastic... | Fludarabine Busulfan Cyclophosphamid... Mycophenolate M... Tacrolimus | 6 Months - 75 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
Haploidentical Donor vs mMUD in Hematological Malignancies | NCT03275636 | AML ALL MDS | Peripheral bloo... | 18 Years - | DKMS gemeinnützige GmbH | |
Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy | NCT00796562 | MDS Leukemias Lymphomas | Busulfan Cyclophosphamid... Total body irra... | 6 Months - 65 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
Haploidentical BMT With Post-Transplant Cyclophosphamide and Bendamustine | NCT02996773 | Acute Lymphobla... Acute Myelogeno... Myelodysplastic... Chronic Myeloge... Lymphoma,Non-Ho... Lymphoma, Hodgk... Lymphoma, Folli... Marginal Zone L... Large Cell Lymp... Mantle-Cell Lym... Gray Zone Lymph... Burkitt Lymphom... High Risk Undif... | Bendamustine Cyclophosphamid... | 4 Years - 30 Years | University of Arizona | |
Stem Cell Transplant Using Peripheral and Cord Blood Stem Cells to Treat Severe Aplastic Anemia and Myelodysplastic Syndrome | NCT00604201 | Myelodysplastic... Severe Aplastic... | Umbilical Cord ... | 4 Years - 75 Years | National Institutes of Health Clinical Center (CC) |